4.5 Article

CHD1 deletion stabilizes HIF1a to promote angiogenesis and glycolysis in prostate cancer

期刊

ASIAN JOURNAL OF ANDROLOGY
卷 25, 期 2, 页码 152-157

出版社

WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/aja202287

关键词

angiogenesis; CHD1; HIF1a; metabolism; prostate cancer

向作者/读者索取更多资源

This study reveals that CHD1 deletion, a common mutation in prostate cancer, enhances HIF1 alpha expression through transcriptional downregulation of PHD2. This leads to the promotion of angiogenesis and metabolic reprogramming in prostate cancer through HIF1 alpha activation. These findings shed light on the role of CHD1 in prostate cancer progression.
Chromodomain-helicase-DNA-binding protein 1 (CHD1) deletion is among the most common mutations in prostate cancer (PCa), but its role remains unclear. In this study, RNA sequencing was conducted in PCa cells after clustered regularly interspaced palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9)-based CHD1 knockout. Gene set enrichment analysis (GSEA) indicated upregulation of hypoxia-related pathways. A subsequent study confirmed that CHD1 deletion significantly upregulated hypoxia-inducible factor 1 alpha (HIF1 alpha) expression. Mechanistic investigation revealed that CHD1 deletion upregulated HIF1 alpha by transcriptionally downregulating prolyl hydroxylase domain protein 2 (PHD2), a prolyl hydroxylase catalyzing the hydroxylation of HIF1 alpha and thus promoting its degradation by the E3 ligase von Hippel-Lindau tumor suppressor (VHL). Functional analysis showed that CHD1 deletion promoted angiogenesis and glycolysis, possibly through HIF1 alpha target genes. Taken together, these findings indicate that CHD1 deletion enhances HIF1 alpha expression through PHD2 downregulation and therefore promotes angiogenesis and metabolic reprogramming in PCa.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据